Persistent Asset Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.2K Sell
56
-1,850
-97% -$1.89M 0.02% 380
2026
Q1
$1.75M Buy
1,906
+1,373
+258% +$1.39M 0.65% 39
2025
Q4
$573K Buy
+533
New +$510K 0.26% 109
2025
Q3
– Sell
-3,404
Closed -$2.53M – 273
2025
Q2
$2.65M Sell
3,404
-1,084
-24% -$842K 1.97% 12
2025
Q1
$3.71M Buy
4,488
+3,020
+206% +$2.51M 3.11% 7
2024
Q4
$1.19M Buy
+1,468
New +$1.22M 0.99% 29

Other funds holding LLY

Persistent Asset Partners's LLY Position: Q2 2026 in Review

Persistent Asset Partners reduced its Eli Lilly (LLY) stake by 97% in Q2 2026, selling an estimated $1.89M and leaving 56 shares worth $67.2K. The position accounts for 0.02% of the portfolio, ranked #380.

Persistent Asset Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.71M in Q1 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Persistent Asset Partners held 56 shares of Eli Lilly worth $67.2K as of Q2 2026.
  • Persistent Asset Partners sold 1,850 Eli Lilly shares in Q2 2026, an estimated $1.89M.
  • Eli Lilly made up 0.02% of Persistent Asset Partners's portfolio in Q2 2026, its #380 holding.
  • Persistent Asset Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Persistent Asset Partners's Eli Lilly position peaked at $3.71M in Q1 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.